13F-HR filed by Patient Square Capital LP
Patient Square Capital LP filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-12, with 23 holding rows worth $645,523,811.
- Accession
- 0001819257-26-000005
- Filer
- CIK 1819257
- Filed
- 2026-08-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 23 entries on the cover page, a total value of $645,523,811 stated on the cover page (in dollars after the unit check, H1), rows summing to $645,523,811 with VALUE read as dollars as filed, 13F file number 028-22927. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ROIVANT SCIENCES LTD | G76279101 | SHS | 8,020,928 | $283,860,642 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 276,000 | $51,689,280 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 260,500 | $30,496,735 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 206,500 | $27,518,190 | dollars as filed | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 90,020 | $25,652,999 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 671,209 | $23,210,407 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 23,000 | $21,338,710 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 37,120 | $20,112,730 | dollars as filed | |
| BELITE BIO INC | 07782B104 | CMN | 110,000 | $16,938,350 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 425,000 | $16,447,500 | dollars as filed | |
| DBV TECHNOLOGIES S A | 23306J309 | SPONSORED ADS | 909,474 | $14,915,374 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 220,000 | $13,279,200 | dollars as filed | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 134,429 | $12,508,618 | dollars as filed | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 355,800 | $10,969,314 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 212,500 | $10,784,375 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 108,000 | $10,527,840 | dollars as filed | |
| ALLOGENE THERAPEUTICS INC | 019770106 | COM | 5,050,000 | $10,504,000 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 720,000 | $10,296,000 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 370,000 | $9,701,400 | dollars as filed | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 1,608,815 | $7,513,166 | dollars as filed | |
| INVENTIVA SA | 46124U107 | ADS | 1,967,171 | $7,435,906 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 47,500 | $5,446,825 | dollars as filed | |
| FAETH THERAPEUTICS INC | 81728A207 | COM NEW | 175,050 | $4,376,250 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001819257-26-000005 | this filing | 2026-08-12 | acceptance time not in the bulk data set |